


Healthcare News Roundup: Interventional Devices
HSMN NewsFeed - 1 Nov 2011
Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME(TM) Drug Eluting Stent
Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME(TM) Drug Eluting Stent
HSMN NewsFeed - 1 Nov 2011
Boston Scientific Announces Schedule of Events at TCT Scientific Symposium
Boston Scientific Announces Schedule of Events at TCT Scientific Symposium
HSMN NewsFeed - 18 Oct 2011
Boston Scientific Completes Enrollment in Benign Stricture Study of WallFlex(R) Biliary RX Stent
Boston Scientific Completes Enrollment in Benign Stricture Study of WallFlex(R) Biliary RX Stent
HSMN NewsFeed - 18 Oct 2011
BIOTRONIK Launches First 20 mm–200 mm Stents on 4 F Platform for Treatment of SFA and BTK Disease
BIOTRONIK Launches First 20 mm–200 mm Stents on 4 F Platform for Treatment of SFA and BTK Disease
HSMN NewsFeed - 11 Oct 2011
iScience Interventional Receives Investment Which Accelerates Microcatheter Commercialization Activities
iScience Interventional Receives Investment Which Accelerates Microcatheter Commercialization Activities
HSMN NewsFeed - 11 Oct 2011
Cardiac Dimensions Announces First Patient Treated in TITAN II Clinical Trial
Cardiac Dimensions Announces First Patient Treated in TITAN II Clinical Trial
HSMN NewsFeed - 5 Oct 2011
Boston Scientific Begins Clinical Trial Enrollment for OMEGA(TM) Platinum Chromium Stent System
Boston Scientific Begins Clinical Trial Enrollment for OMEGA(TM) Platinum Chromium Stent System
HSMN NewsFeed - 21 Sep 2011
STENTYS Completes Enrollment of APPOSITION III Study for its Self-Apposing Stent to Treat Heart Attacks
STENTYS Completes Enrollment of APPOSITION III Study for its Self-Apposing Stent to Treat Heart Attacks
HSMN NewsFeed - 13 Sep 2011
Boston Scientific Names Michael F. Mahoney as Company President, Announces CEO Transition Plan
Boston Scientific Names Michael F. Mahoney as Company President, Announces CEO Transition Plan
